chronic critical limb ischemia

Transcatheter Mitral Valve Replacement: DOAC or VKA?

Severe mitral disease is common and currently constitutes a frequent cause of hospitalization and death. While surgery is the treatment of choice, transcatheter mitral valve replacement (TMVR) emerges as a valid alternative in cases of bioprosthesis failure, ring malfunction, or severe mitral annular calcification (MAC). Furthermore, the latest medical guidelines support the recommendation of TMVR<a href="https://solaci.org/en/2024/01/26/transcatheter-mitral-valve-replacement-doac-or-vka/" title="Read more" >...</a>

SAFE-AAA: ¿Son seguros los dispositivos Endologix en aneurisma de aorta abdominal? Seguimiento a 3 años

Intramural Hematoma

Intramural hematoma (IMH) is considered a subtype of acute aortic syndrome (AAS), and some authors describe it as a developmental stage that might cause high morbimortality events such as dissection, aneurysm, or aortic rupture.&nbsp; One of the CT findings associated with IMH is focal contrast enhancement (FCE) within the intramural hematoma, with a reported incidence<a href="https://solaci.org/en/2024/01/24/intramural-hematoma/" title="Read more" >...</a>

Cilostazol en pacientes diabéticos con revascularización periférica endovascular: Un paso más allá de la mejoría sintomática

Cilostazol in Diabetic Patients with Endovascular Peripheral Revascularization: One Step Beyond Symptom Improvement

In patients with peripheral vascular disease (PVD), the presence of diabetes has been significantly associated with increased failure of critical lower limb ischemia (CLI) treatment, and higher incidence of amputation. This relationship has been attributed mainly to comorbidities and patient characteristics, concomitant peripheral neuropathy and marked microvascular alteration. Also, a high proportion of these patients<a href="https://solaci.org/en/2023/11/24/cilostazol-in-diabetic-patients-with-endovascular-peripheral-revascularization-one-step-beyond-symptom-improvement/" title="Read more" >...</a>

El uso de imágenes intravasculares para guiar la angioplastia reduce el riesgo de muerte cardiovascular en comparación con la angiografía

AQCA Study: Pre-PCI Virtual QFR for Planning PCI vs. Conventional Angiography

Several studies have used physiological assessment after a percutaneous coronary intervention (PCI) to improve clinical outcomes. However, results are not entirely conclusive. The limitations of using these physiological assessment methods are the need for extra measurements with increased procedure time, more radiation, and more contrast, which in turn leads to higher costs.&nbsp; To counteract these<a href="https://solaci.org/en/2023/04/05/aqca-study-pre-pci-virtual-qfr-for-planning-pci-vs-conventional-angiography/" title="Read more" >...</a>

Reestenosis de bordes con stents liberadores de everolimus

Arterial Patency in Femoropopliteal Disease with Drug-Eluting Balloons

Follow-up of drug-coated balloon angioplasty in femoropopliteal disease in a real-world population. Using drug-releasing devices has decreased the rate of restenosis in obstructive femoropopliteal lesions compared with conventional balloons or conventional stents (bare-nitinol stent, BNS). Both in the placement of BNS and of drug-eluting stents (DES) there is a mechanical risk of stent fracture or<a href="https://solaci.org/en/2023/02/22/arterial-patency-in-femoropopliteal-disease-with-drug-eluting-balloons/" title="Read more" >...</a>

8 artículos sobre Oclusiones Crónicas Totales que no puede dejar de leer

An Effort Worth Your While: Rechanneling vs. Optimal Medical Treatment in Total Occlusions

Successful rechanneling of a chronic total occlusion (currently around 90%) leads to significant improvement in quality of life and symptom frequency in patients with stable chronic angina compared with optimal medical treatment alone. These results are promising and what we ultimately expected, although symptoms, as a primary endpoint in themselves, are in the eye of<a href="https://solaci.org/en/2018/09/14/an-effort-worth-your-while-rechanneling-vs-optimal-medical-treatment-in-total-occlusions/" title="Read more" >...</a>

Over 10 Keynote Conferences Confirmed at SOLACI-SOCIME 2018 Congress

We are less than a month away from the most important interventional cardiology event in Latin America. Consequently, we have started to share information on some of the most appealing sessions that you will be able to enjoy in Mexico City from August 1st to 3rd, 2018. On that vein, we are pleased to communicate<a href="https://solaci.org/en/2018/07/03/mas-de-10-conferencias-magistrales-confirmadas-en-el-congreso-solaci-socime-2018/" title="Read more" >...</a>

What’s New in the European Guidelines on Peripheral Arterial Disease

Since the last version of the European guidelines on the diagnosis and treatment of peripheral arterial disease in 2011, there have been many trials and registries that warrant guideline adjustments in many aspects. The first novelty is the teamwork that gave way to these guidelines, which were written in collaboration with the European Society of<a href="https://solaci.org/en/2018/04/04/whats-new-in-the-european-guidelines-on-peripheral-arterial-disease/" title="Read more" >...</a>

El uso de imágenes intravasculares para guiar la angioplastia reduce el riesgo de muerte cardiovascular en comparación con la angiografía

The Use of Intravascular Imaging to Guide PCI Reduces Cardiovascular Death Risk, Compared to Angiography

Intravascular imaging, which includes&nbsp;ultrasound intravascular (IVUS) and optical coherence tomography (OCT), shows live details that better characterize post&nbsp;stenting plaque, anatomy and outcomes. &nbsp;The already familiar limitations of the&nbsp;angiography has lead us to think that IVUS and OCT could improve clinical outcomes; however, we should still find the evidence to support this claim. To shed some<a href="https://solaci.org/en/2018/01/16/the-use-of-intravascular-imaging-to-guide-pci-reduces-cardiovascular-death-risk-compared-to-angiography/" title="Read more" >...</a>

Zilver-PTX

Zilver PTX: Maintains efficacy in real life most challenging lesions?

Original Title: Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan 12-Month Results. Reference: Hiroyoshi Yokoi et al. J Am Coll Cardiol Intv. 2016;9(3):271-277. &nbsp; This multicenter prospective study carried out in Japan assessed the paclitaxel eluting stent Zilver PTX in an unselected real world population very different to<a href="https://solaci.org/en/2016/05/17/zilver-ptx-maintains-efficacy-in-real-life-most-challenging-lesions/" title="Read more" >...</a>

Top